The natural history of HCV in a cohort of haemophilic patients infected between 1961 and 1985
about
What we should know about portal vein thrombosis in cirrhotic patients: a changing perspectiveCorrelates of spontaneous clearance of hepatitis C virus among people with hemophiliaFactors influencing a low rate of hepatitis C viral RNA clearance in heroin users from Southern ChinaInfluence of hepatitis C virus and IL28B genotypes on liver stiffnessThe evolution of comprehensive haemophilia care in the United States: perspectives from the frontline.Human immunodeficiency and hepatitis virus infections and their associated conditions and treatments among people with haemophilia.Guidelines on the diagnosis, management and prevention of hepatitis in haemophilia.Hepatitis B and hepatitis C co-infection in patients with HIV.Impact of HIV on liver fibrosis in men with hepatitis C infection and haemophilia.The natural history and antiviral treatment of hepatitis C in haemophilia.Diagnosis and management of paediatric hepatitis C virus infection.Transjugular liver biopsy is safe and diagnostic for patients with congenital bleeding disorders and hepatitis C infection.Hepatitis C and HIV-1 coinfection.Impact of human immunodeficiency virus (HIV) infection on the progression of liver fibrosis in hepatitis C virus infected patientsHIV and HCV coinfection in haemophilia.HIV/hepatitis C coinfection natural history and disease progression.Plasma for fractionation: safety and quality issues.Evidence of distinct populations of hepatitis C virus in the liver and plasma of patients co-infected with HIV and HCV.HCV/ HIV co-infection: time to re-evaluate the role of HIV in the liver?Treatment of chronic hepatitis C in patients with haemophilia: a review of the literature.Seroprevalence of hepatitis C, hepatitis B and HIV viruses in hemophiliacs born 1985-2010 in west Azarbaijan of IranIs time to treat for HCV all the HIV/HCV co-infected hemophiliacs?Impact of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis.Co-Infection of the Hepatitis C Virus With Other Blood-Borne and Hepatotropic Viruses Among Hemophilia Patients in Poland.Hepatitis C Virus and HIV Type 1 Co-Infection.Morbidity and mortality profile of human immunodeficiency virus-infected patients with and without hepatitis C co-infection.Management of adverse effects of Peg-IFN and ribavirin therapy for hepatitis C.Viral cirrhosis: an overview of haemostatic alterations and clinical consequencesRole of exercise and physical activity on haemophilic arthropathy, fall prevention and osteoporosis.The aging patient with hemophilia.Role of GB virus C in modulating HIV diseaseMortality and causes of death in patients with hemophilia, 1992-2001: a prospective cohort study.Outcome of liver transplantation in patients with hereditary bleeding disorders: a single centre UK experience.The Natural History of Hepatitis C Virus Infection in Hemophiliacs.Elbasvir/Grazoprevir for Patients With Hepatitis C Virus Infection and Inherited Blood Disorders: A Phase III Study.Clinical laboratory assessment of hepatitis C and HIV coinfected patients according to the antiretroviral therapy received.The association of non-O blood group and severity of liver fibrosis in patients with chronic hepatitis C infection.Ledipasvir-sofosbuvir and sofosbuvir plus ribavirin in patients with chronic hepatitis C and bleeding disorders.The effect of highly active antiretroviral therapy for HIV on the anti-HCV specific humoral immune response.Long term survival in persons with hemophilia and chronic hepatitis C: 40 year outcomes of a large single center cohort
P2860
Q26827793-D1E92CB3-99BB-4F4F-89EE-AEBD921A51AEQ27480307-81857CF4-D1C0-4C14-B00C-C0130DA32880Q27488825-237681CD-19D0-47F1-AD5D-60EAC9DEB23CQ28542906-B6A3605C-2C75-4E45-A180-D5927EE03413Q30249256-D5D92A9E-F73F-491A-BA5A-39B9433D6B1AQ33363196-F00735C0-2B58-4BC7-A826-3606A3B7F7C9Q34301709-110F8C1E-70AC-4292-A9F7-F12510F5994AQ34323219-B5F5FAE0-92EF-4359-B8B4-6380F864C7EEQ34345002-A5E57E2A-6F32-42CC-A80D-9404E6D17360Q34637021-16F02864-1840-4B70-A6AF-59A5624FBC1BQ34669464-239DFA1A-7E7A-46A6-9630-626C338AB1C9Q35544359-1FC8687F-E3ED-4CAA-B5C1-DF572731706AQ35595027-478AAA6E-2E83-4CFB-8093-F23845ADAD91Q35595809-5647A41F-2766-4094-B238-FAC328FD4F16Q35666754-3CBF8C1F-ADAF-4F32-B2FD-EF07F5C00DBEQ35801431-1995D004-AE2B-472C-AC29-139C7D517BE8Q35824851-C4E83301-A28A-4577-A05E-1FB75C07BEE6Q36034450-EE14DBB4-BC3D-4FA5-BD47-E31B9F4F0A68Q36479368-40AC9652-825D-4258-8516-36CEF86A8E6EQ36570893-E33424E6-FE70-4F59-86ED-7121608951C8Q36732691-9B2A1B84-8891-4150-93C9-F85881E5E471Q36746459-8B304E01-2719-43E9-BBD4-476B39638724Q37122490-5619F524-06B6-455C-8A5C-B6524D8A25D8Q37383718-74EBBAAF-D808-43B7-80AF-C180C4805B65Q37481988-DCFF2C48-FC0E-4334-B51A-3B2747B0EE76Q37609379-03FCC947-D3E1-4B31-995B-02CDBF95E774Q37851006-1A64B53E-3277-4787-8BF7-D9EC781604D5Q37854462-04D852D7-CC4B-4BE0-8426-2B21E087860DQ37857364-36BC3E55-41E4-425E-A5F0-55624EE7A509Q37995101-F818B70E-2B6A-46E5-9E8E-841E0A26AA09Q38018981-1968CE36-CFBD-4174-8BDE-8E4A0828244FQ38469705-9742F7C4-54F8-4A97-8596-36B085C0F1D1Q38756859-BD7F3D87-4528-4FC7-A0E1-C10B546F7BFAQ38897747-D7BF5345-82F1-4653-8322-DF3DBC5726AEQ38931266-86663BC3-7A3C-47F5-BD32-B89760C4AEDBQ39296271-28AE2368-6402-40D0-BB9C-3D18BAB49F4AQ40037618-71053076-7E20-43B5-AD90-6E6BCAAD999CQ40357542-E0699D4B-9ACF-42EA-B116-2CCD85115ED7Q40543167-114357F3-B1F5-4D67-82F2-A5EE492349A3Q40663403-006CA6ED-1F62-4EB9-BDB8-98CB6A76628E
P2860
The natural history of HCV in a cohort of haemophilic patients infected between 1961 and 1985
description
2000 nî lūn-bûn
@nan
2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
The natural history of HCV in ...... infected between 1961 and 1985
@ast
The natural history of HCV in ...... infected between 1961 and 1985
@en
type
label
The natural history of HCV in ...... infected between 1961 and 1985
@ast
The natural history of HCV in ...... infected between 1961 and 1985
@en
prefLabel
The natural history of HCV in ...... infected between 1961 and 1985
@ast
The natural history of HCV in ...... infected between 1961 and 1985
@en
P2093
P2860
P356
P1433
P1476
The natural history of HCV in ...... infected between 1961 and 1985
@en
P2093
P2860
P304
P356
10.1136/GUT.47.6.845
P407
P577
2000-12-01T00:00:00Z